Skip to main content
Premium Trial:

Request an Annual Quote

Kosan Licenses IP From Lilly

NEW YORK, Aug. 20 - Kosan Biosciences today said it has bought an exclusive license to certain IP owned by drug maker Eli Lilly that can help the company develop polyketides as pharmaceutical products.

 

Kosan said the license, which covers discoveries related to polyketide synthesis genes and methods for the genetic engineering of polyketide-producing organisms, includes rights to some 23 US patents, 49 foreign patents, and an undisclosed number of pending patents.

The Scan

Purnell Choppin Dies

Purnell Choppin, a virologist who led the Howard Hughes Medical Institute, has died at 91, according to the Washington Post.

Effectiveness May Decline, Data From Israel Suggests

The New York Times reports that new Israeli data suggests a decline in Pfizer-BioNTech SARS-CoV-2 vaccine effectiveness against Delta variant infection, though protection against severe disease remains high.

To See Future Risk

Slate looks into the use of polygenic risk scores in embryo screening.

PLOS Papers on Methicillin-Resistant Staphylococcus, Bone Marrow Smear Sequencing, More

In PLOS this week: genomic analysis of methicillin-resistant Staphylococcus pseudintermedius, archived bone marrow sequencing, and more.